ATE302789T1 - Zellkernmatrixproteine - Google Patents

Zellkernmatrixproteine

Info

Publication number
ATE302789T1
ATE302789T1 AT94907435T AT94907435T ATE302789T1 AT E302789 T1 ATE302789 T1 AT E302789T1 AT 94907435 T AT94907435 T AT 94907435T AT 94907435 T AT94907435 T AT 94907435T AT E302789 T1 ATE302789 T1 AT E302789T1
Authority
AT
Austria
Prior art keywords
matrix proteins
nuclear matrix
cell nuclear
nmps
nmp
Prior art date
Application number
AT94907435T
Other languages
English (en)
Inventor
Donald S Coffey
Alan W Partin
Robert H Getzenberg
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Application granted granted Critical
Publication of ATE302789T1 publication Critical patent/ATE302789T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
AT94907435T 1993-02-09 1994-02-08 Zellkernmatrixproteine ATE302789T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1562493A 1993-02-09 1993-02-09
PCT/US1994/001360 WO1994018222A1 (en) 1993-02-09 1994-02-08 Nuclear matrix proteins

Publications (1)

Publication Number Publication Date
ATE302789T1 true ATE302789T1 (de) 2005-09-15

Family

ID=21772525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94907435T ATE302789T1 (de) 1993-02-09 1994-02-08 Zellkernmatrixproteine

Country Status (7)

Country Link
US (7) US5824490A (de)
EP (1) EP0684955B1 (de)
JP (1) JPH08508396A (de)
AT (1) ATE302789T1 (de)
CA (1) CA2155645A1 (de)
DE (1) DE69434470T2 (de)
WO (1) WO1994018222A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08508396A (ja) * 1993-02-09 1996-09-10 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 核マトリックスタンパク質
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US6280956B1 (en) * 1995-11-03 2001-08-28 University Of Pittsburgh Antibodies to bladder cancer nuclear matrix proteins and their use
US5866535A (en) * 1995-11-03 1999-02-02 University Of Pittsburgh Bladder nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US5914238A (en) * 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer
US6232443B1 (en) * 1997-04-08 2001-05-15 University Of Pittsburgh Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
GB9721901D0 (en) * 1997-10-16 1997-12-17 Univ Manchester Particles
JPH11232291A (ja) * 1998-02-16 1999-08-27 Seibutsu Bunshi Kogaku Kenkyusho:Kk 蛋白質立体構造データベース検索方法
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
CA2338982C (en) * 1998-08-10 2011-03-15 Urogenesys, Inc. Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
WO2000023624A1 (en) * 1998-10-22 2000-04-27 Duke University Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
US6617432B1 (en) * 1999-10-15 2003-09-09 University Of Pittsburgh Nuclear matrix proteins polynucleotide sequences encoding them and their use
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
AU2003247576A1 (en) * 2002-06-18 2003-12-31 Archemix Corp. Aptamer-toxin molecules and methods for using same
US20040249130A1 (en) * 2002-06-18 2004-12-09 Martin Stanton Aptamer-toxin molecules and methods for using same
US8853376B2 (en) 2002-11-21 2014-10-07 Archemix Llc Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US20050118102A1 (en) * 2003-04-28 2005-06-02 Intematix Corporation Spin resonance heating and/or imaging in medical applications
WO2006116021A2 (en) * 2005-04-22 2006-11-02 Intematix Corporation Mri technique based on electron spin resonance and endohedral contrast agent
DE102007037008B4 (de) * 2007-08-06 2015-09-10 Siemens Aktiengesellschaft Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882268A (en) * 1985-12-24 1989-11-21 Massachusetts Institute Of Technology Method for determining tissue of origin and degree of malignancy of tumor cells
JPH05146294A (ja) * 1991-11-27 1993-06-15 Sankyo Co Ltd 癌関連蛋白質
EP0647270B1 (de) * 1992-06-22 2004-01-07 Matritech, Inc. Neuartige marker maligner zelltypen in der inneren nukleären matrix
JPH08508396A (ja) * 1993-02-09 1996-09-10 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 核マトリックスタンパク質

Also Published As

Publication number Publication date
US5824490A (en) 1998-10-20
DE69434470T2 (de) 2006-06-22
US20020168695A1 (en) 2002-11-14
CA2155645A1 (en) 1994-08-18
WO1994018222A1 (en) 1994-08-18
US20030143621A1 (en) 2003-07-31
EP0684955A4 (de) 1997-07-30
US5849509A (en) 1998-12-15
EP0684955B1 (de) 2005-08-24
US20060172352A1 (en) 2006-08-03
EP0684955A1 (de) 1995-12-06
DE69434470D1 (de) 2005-09-29
JPH08508396A (ja) 1996-09-10
US5874539A (en) 1999-02-23
US6030793A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
ATE302789T1 (de) Zellkernmatrixproteine
DE68927511D1 (de) DNS-Sequenzen, die Polypeptiden mit beta-1,3-Glukanase-Aktivität codieren
PT939767E (pt) Factor viii porcino e seus hibridos
ATE173505T1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
DE69419678D1 (de) Entwurfsverfahren für luftreifen
NO892033L (no) Fibronectinbindende protein.
DE68914664D1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
DE68902784T2 (de) Auswechselbarer quenchgas-injektionsring.
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
MX9705025A (es) Proteinas de matriz nuclear de vejiga y su uso para detectar y tratar trastornos proliferativos celulares.
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
ATE314477T1 (de) An der streptogramin biosynthese beteiligte polypeptide, ihre kodierenden nukleotidsequenzen und ihre verwendung
DE68908839D1 (de) Anordnung zur Fehlerstrombegrenzung.
DE69006149T2 (de) Kohlenstoffelektrode.
EP1132402A4 (de) Peptidfragmente mit den zelltod verhindernden aktivität
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
MX9702863A (es) Proteinas asociadas con el hipocampo, secuencias de adn que codifican para las mismas y usos de las mismas.
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
DK1342729T3 (da) Antistoffer og antisense-molekyler for G-koblet receptor der udviser selektiv affinitet for ATP
PE20399A1 (es) Muteina ob
DK0941341T3 (da) Nukleotidsekvens, der koder for en flavinmonooxygenase, det tilsvarende protein og deres anvendelser inden for diagnostik og terapi
WO2001029218A3 (en) Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
NO880099D0 (no) Beskyttelseskrage for karbonanoder.
DE69420445D1 (de) Schalter für eine HF-Quelle
DK43393D0 (da) Dna-sekvens, der koder for et enzym

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties